KR20010026947A - Sub-food manufecturing method - Google Patents
Sub-food manufecturing method Download PDFInfo
- Publication number
- KR20010026947A KR20010026947A KR1019990038463A KR19990038463A KR20010026947A KR 20010026947 A KR20010026947 A KR 20010026947A KR 1019990038463 A KR1019990038463 A KR 1019990038463A KR 19990038463 A KR19990038463 A KR 19990038463A KR 20010026947 A KR20010026947 A KR 20010026947A
- Authority
- KR
- South Korea
- Prior art keywords
- chitosan
- weight
- chitin
- food
- blood
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 10
- 229920001661 Chitosan Polymers 0.000 claims abstract description 27
- 229920002101 Chitin Polymers 0.000 claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims description 13
- 241001474374 Blennius Species 0.000 claims description 11
- 235000015872 dietary supplement Nutrition 0.000 claims description 10
- 210000001161 mammalian embryo Anatomy 0.000 claims description 7
- 241000251468 Actinopterygii Species 0.000 claims description 5
- 206010003246 arthritis Diseases 0.000 abstract description 12
- 238000002156 mixing Methods 0.000 abstract description 5
- 230000009931 harmful effect Effects 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 240000000691 Houttuynia cordata Species 0.000 abstract description 3
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract description 3
- 240000007594 Oryza sativa Species 0.000 abstract description 3
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 235000009566 rice Nutrition 0.000 abstract description 3
- 241000195950 Equisetum arvense Species 0.000 abstract 2
- 239000005768 Equisetum arvense L. Substances 0.000 abstract 2
- 244000052616 bacterial pathogen Species 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000011369 resultant mixture Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 241000512259 Ascophyllum nodosum Species 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 10
- 229910001385 heavy metal Inorganic materials 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 7
- 210000000653 nervous system Anatomy 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- 241000238557 Decapoda Species 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 208000017667 Chronic Disease Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000005686 eating Nutrition 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000036544 posture Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 206010041349 Somnolence Diseases 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- -1 steroid compounds Chemical class 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000000596 hypostatic effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000005495 thyroid hormone Substances 0.000 description 2
- 229940036555 thyroid hormone Drugs 0.000 description 2
- 206010043778 thyroiditis Diseases 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- PAZVGJKHZQNJTB-VUJYQTOSSA-N (6-hydroxy-7-methoxy-4-oxo-2-phenylchromen-5-yl) (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)O)C(=O)OC=1C=2C(=O)C=C(OC=2C=C(C=1O)OC)C=1C=CC=CC=1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PAZVGJKHZQNJTB-VUJYQTOSSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- IWHXNINOLLNFGP-ZAGWXBKKSA-N Cl.CCOc1ccc(cc1)\N=N\c1ccc(N)cc1N Chemical compound Cl.CCOc1ccc(cc1)\N=N\c1ccc(N)cc1N IWHXNINOLLNFGP-ZAGWXBKKSA-N 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 244000108484 Cyperus difformis Species 0.000 description 1
- 235000005885 Cyrtosperma chamissonis Nutrition 0.000 description 1
- 244000285955 Cyrtosperma chamissonis Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 201000004458 Myoma Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- CJXHWGWCRRLZQB-UHFFFAOYSA-N Palustrin Natural products COc1cc2OC(=CC(=O)c2c(OC3OC(C(OC4OC(CO)C(O)C(O)C4O)C(O)C3O)C(=O)O)c1O)c5ccccc5 CJXHWGWCRRLZQB-UHFFFAOYSA-N 0.000 description 1
- YMALJVLSPODBKM-UHFFFAOYSA-N Palustrine Natural products C1C(=O)NCCCCNCCCN2C(C(O)CC)C=CCC21 YMALJVLSPODBKM-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- MSWZFWKMSRAUBD-YDMGZANHSA-N beta-D-Glucosamine Natural products N[C@H]1[C@H](O)O[C@@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-YDMGZANHSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- PHMDYZQXPPOZDG-UHFFFAOYSA-N gallane Chemical compound [GaH3] PHMDYZQXPPOZDG-UHFFFAOYSA-N 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002478 hand joint Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 229940089454 lauryl aldehyde Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000035409 positive regulation of cell proliferation Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000007371 visceral function Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/511—Chitin, chitosan
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 인체의 류머티스 관절염 및 신경계통의 질환을 예방하거나 치료를 위한 건강 보조식품 제조방법에 관한 것으로 특히, 손가락 및 발가락, 척추, 무릎관절, 산후풍 및 신경계통에 효과적으로 작용하여 질병을 예방하거나 호전시킬 수 있는 건강 보조식품 제조방법에 관한 것이다.The present invention relates to a method for producing a health supplement for preventing or treating rheumatoid arthritis and diseases of the nervous system of the human body, in particular, to effectively prevent or improve disease by acting effectively on the fingers and toes, spine, knee joints, postpartum and nervous system It relates to a method of manufacturing a health supplement that can be made.
최근 급속한 산업화에 힘입어 문명이 급속도로 발전하였으나 상대적으로 자연환경을 오염시킨 것도 부인할 수 없는 사실이다. 이러한 환경속에 생활하면서 과거에는 들어도 못 본 병에 걸려 생명을 잃는 일도 매우 흔한 일임을 볼 수 있다.Although civilization has developed rapidly due to the recent rapid industrialization, it is undeniable that it has relatively polluted the natural environment. Living in such an environment, it is very common to lose a life due to a disease that has never been heard in the past.
최근 현대인들에게 있어 아황산가스, 다이옥신, 매연, 각종 중금속 등으로 인한 환경오염(대기 및 수질오염)은 각종 유해물질들이 인체에 축적되어(중금속) 각종 질병의 직접적인 원인이 되고 있으며, 또 불규칙하고 편중된 식생활은 영양결핍, 소화기 계통의 질병을 야기하고, 또 컴퓨터 등으로 업무를 처리하는 사무직 근무자에게 흔히 볼 수 있듯이 근무자세에서 신체사용의 불균일로 인해 근육 및 뼈의 불균형한 발달 및 성장으로 인한 질환(관절염, 요통, 근육통) 등 현대인에게 흔한 병이 되었다.Recently, environmental pollution (air and water pollution) caused by sulfurous acid gas, dioxin, soot, and various heavy metals is a direct cause of various diseases due to various harmful substances accumulated in the human body (heavy metal). Eating habits cause malnutrition, diseases of the digestive system, and diseases caused by unbalanced development and growth of muscles and bones due to uneven use of the body in the working posture, as is common with office workers who work with computers. (Arthritis, back pain, muscle pain) has become a common disease in modern people.
실제로 성인 남녀 중 약 83%이상이 소화기계통, 요통 및 관절이상의 질환을 앓고 있다는 발표 내용을 보더라도 현대인에게 매우 흔하게 만연된 질병이다.Indeed, more than 83% of adult men and women are suffering from diseases of the digestive system, back pain, and joint abnormalities.
이러한 관절 이상현상은 대개 장시간에 걸쳐 진행된 경우가 많은데 일 예로, 불편한 신발을 신었을 때 발가락, 혹은 발의 모양이 기형화되는 것과 같이 보행자세, 앉은 자세, 서있는 자세 등등 장기간에 걸쳐 특정한 형태로 변형되면서 나타나는 현상이라 볼 수 있다. 대개 이러한 질병은 선천적인 이상보다는 후천적으로 발생되는 요인이 상대적으로 많기 때문에 미리 예방하는 것이 매우 중요하다. 물론 갑작스런 사고로 발생되는 경우도 있으나 평상시 규칙적인 적당한 운동과 바른 자세를 습관화하는 것이 좋다. 외적요인 이외에도 내적요인 즉, 비만, 각종 수질과 대기오염 정도, 환경오염으로 인한 중금속의 체내축척 등 후천적으로 발생될 수도 있으므로 항시 건강을 위해 주의해야만 한다. 그리고, 임산부들에게 출산후 산후조리를 안정적으로 받지 못할 경우에 산후풍으로 고생하는 경우가 많다. 이 산후풍은 일반적으로 바람들었다라고 말하고 있는데, 특히 관절등에서 주로 발생한다. 이러한 산후풍은 관절뿐만 아니라 신경계통에도 영향을 주어 손발이 붓거나 저리거나 시큰거림 현상이 나타나는데 쉽게 치료되지 않고 있다.These joint abnormalities are usually progressed for a long time. For example, when an uncomfortable shoe is worn, the shape of the toe or the foot is deformed, such as pedestrians, sitting postures, standing postures, etc. This can be seen. In general, it is very important to prevent these diseases in advance, because there are relatively many factors that occur rather than congenital abnormalities. Of course, it can be caused by a sudden accident, but it is good practice to make regular exercise and proper posture. In addition to external factors, internal factors such as obesity, various kinds of water quality and air pollution, and the accumulation of heavy metals due to environmental pollution may be acquired. In addition, when pregnant women do not receive postpartum care stably after giving birth, they often suffer from postpartum wind. This postpartum is usually said to have been winded, especially in the joints. These postpartum winds affect the nervous system as well as the joints, resulting in swelling, numbness and tingling of the hands and feet.
따라서, 본 발명은 특히 내적요인에 의해 발생되는 각종 관절염과 각종 내장기관, 혈관 혈액 및 신경계통에 이상을 예방할 수 있는 건강보조식품 제조방법을 창안하게 되었다.Accordingly, the present invention has been made a method for producing a health supplement food that can prevent abnormalities in various arthritis and various internal organs, blood vessels and nervous system caused by internal factors in particular.
본 발명의 목적은 산후풍과 같은 질병에 유용하고, 일상생활에서 건강보조식품으로 섭취함으로써 잠재적으로 발생 할 수도 있는 관절염 혹은 신경계통 질환을 예방할 수 있는 보조식품제조방법을 제공하는데 있다.Disclosure of Invention An object of the present invention is to provide a method for preparing a supplement, which is useful for diseases such as postpartum wind and can prevent arthritis or nervous system diseases that may potentially occur by ingesting as a dietary supplement in daily life.
본 발명의 다른 목적은 인체에 무해한 자연식물만을 이용함으로 보조식품의 섭취로 인한 이차적인 인체(人體)기능의 불균형 혹은 또 다른 질병(치료로 인한 후유증)이 발생되지 않도록 예방하는데 있다.Another object of the present invention is to prevent the occurrence of secondary imbalances or other diseases (aftereffects caused by treatment) caused by the intake of supplements by using only natural plants harmless to the human body.
본 발명은 관절염 특히 관절염(류머티스), 간, 신장, 혈액 및 신경계에 따른 질환예방 및 치료에 관한 것이다. 일반적으로 특히 관절염의 경우, 한방치료로서는 침술이나 뜸, 찜질, 마사지 탕약처방에 의한 치료가 주로 시행되고, 양약처방으로는 수술 및 약물투여방식으로 주로 이루어지고 있다.The present invention relates to the prevention and treatment of diseases according to arthritis, in particular arthritis (rheumatic), liver, kidney, blood and nervous system. In general, especially in the case of arthritis, herbal treatment is mainly performed by acupuncture, moxibustion, poultice, massage decoction, and prescription medicine is mainly performed by surgery and drug administration.
본 발명은 신체의 기능을 보(保)할 수 있도록 하고, 순수 자연식물을 이용하여 관절염 및 신경계통을 치료하거나 예방할 수 있도록 하는데 주된 목적이 있음으로, 인체에 무해한 건강보조식품 제조방법을 개발하는데 있다.The present invention has a main object to ensure the function of the body (body), and to treat or prevent arthritis and nervous system using pure natural plants, to develop a method for manufacturing health supplement food harmless to the human body have.
먼저 본 발명은 다시마, 키틴/키토산, 어성초, 문형, 함초, 배아(쌀의 눈)로 구성되는데, 이해를 돕기 위해 본 발명에 따른 상기 성분별 특징, 약리작용 및 효능을 설명하면 다음과 같다.First, the present invention is composed of kelp, chitin / chitosan, eoseongcho, sentence, hamcho, embryo (rice eye), the characteristics, pharmacological action and efficacy of the components according to the present invention for the purpose of understanding.
다시마는 탄수화물이 약 60% 정도 차지하며, 알긴만니트 갈락란, 비타민, 20여종의 단백질, 아미노산, 스테로이드 화합물, 색소, 미량의 기름 및 45종의 미네랄 등이 포함되어 있다. 다시마는 동의보감에는 곤포라고 소개되어 있는데 특유의 알긴산 섬유질, 요오드, 칼슘(Ca), 칼륨(K), 나트륨(Na), 마그네슘 (Mg), 세레늄등 무려 100여가지의 영양소를 함유하고 있는 영양소의 보고이며, 풍부한 섬유질 식품이며, 풍부한 요오드 식품이며, 뛰어난 다이어트 식품이다. 노벨의학상을 수상한 (구)소련의 생물학자 메치니코프 박사는 장벽에 끼는 숙변으로 인해 많은 병이 발생하여 노화가 빨리 진행된다는 사실을 밝혀냈습니다. 성인 일반인에게는 약 1∼5Kg 심한 사람은 장속에 10∼20Kg정도 숙변이 정체되어 있으며, 이유없는 부스럼, 여드름, 얼룩짐, 기미, 주근깨 등과 같이 피부가 거칠어지는 것과 말초혈관의 혈액순환장애로 두통이 잦는 것도, 만성병에 약효가 저하되는 이유도 바로 숙변이 원인이다.Kelp is about 60% carbohydrate and contains alginmannit gallan, vitamins, 20 proteins, amino acids, steroid compounds, pigments, trace oils and 45 minerals. Kelp is introduced as a packing in the synonym of nutrients containing 100 kinds of nutrients such as alginate fiber, iodine, calcium (Ca), potassium (K), sodium (Na), magnesium (Mg) and serenium. It is a report, it is a rich fibrous food, a rich iodine food, and an excellent diet food. Dr. Mechinnikov, a former Soviet biologist who won the Nobel Prize in medicine, found that the hunger on the wall causes many diseases, leading to rapid aging. Adults have about 1 to 5 kg of severe stool in the intestine, and 10 to 20 kg of stool is stagnant.The skin is rough, such as unexplained swelling, acne, stains, blemishes, and freckles. In addition, the reason for the decrease in efficacy of chronic disease is the cause of stool.
다시마는 장의 내벽에 축적된 콜타르와 같이 검고 끈적끈적한 숙변이 제거시켜 변이 점차 황금색으로 변하면서 뱃속이 편안하게 해준다.Kelp, like coal tar accumulated on the inner wall of the intestine, is removed from the black and sticky stool, so that the stools gradually turn golden and make the stomach comfortable.
다시마는 칼로리가 제로에 가까운 식품으로 알긴산에 의해 지방이 흡수 배출됨으로써 비만 특히 복부비만에 효과가 우수하다. 또한 다시마에 풍부한 요오드는 목밑에 있는 갑상선 호로몬 분비를 촉진시키며, 갑상선호로몬은 지방을 분해시키는데 매우 중요한 역할을 한다. 그리고 칼륨(K)은 체내에 과다한 수분을 체외로 배출시키는 작용을 하고, 비타민B는 지방을 에너지로 발산하는데 중요한 역활을 한다.Kelp is a calorie-free food that absorbs and releases fat by alginic acid, which is particularly effective for obesity, especially abdominal obesity. In addition, iodine rich in kelp stimulates the secretion of thyroid hormones in the neck, and thyroid hormones play an important role in breaking down fat. Potassium (K) acts to release excess moisture in the body, and vitamin B plays an important role in releasing fat into energy.
아울러, 다시마는 탁월한 알칼리성식품임으로, 섭취시 체내에서 혈액이 약알칼리화됨으로 체질개선에 효과가 있으며, 그 결과 당뇨병 예방이나 개선에 효과가 있다. 그리고 식물섬유는 포도당이 혈액속으로 침투하는 것을 지연시키고, 비타민 B6, 비타민 C는 인슐린의 생성을 촉진시킨다.In addition, since kelp is an excellent alkaline food, the blood is weakly alkaline in the body when ingested, which is effective in improving the constitution, and as a result, it is effective in preventing or improving diabetes. And plant fiber delays the penetration of glucose into the blood, and vitamin B6 and vitamin C promote the production of insulin.
다시마 성분 중 알긴산은 장내 숙변, 변비를 해결함으로써 혈액을 맑게하고, 콜레스테롤을 감소시켜 혈압 강하작용을 한다. 다시마에 들어 있는 요오드는 부신에서 분비되는 아드레날린 호로몬의 작용을 억제시킴으로써 혈압을 저하시킨다. 또 칼륨(K)은 나트륨(염분)을 중화시키는 기능이 있어, 나트륨에 의한 혈압 상승을 억제한다. 따라서 현대인의 만성질환인 고혈압과 당뇨병 예방과 치료에 탁월한 식품이며 비만에도 효과적이다. 당연히 스태미나 식품으로도 가장 좋다. 이러한 이유로 최근에는 다시마 엑기스가 개발되어 널리 보급되고 있다. 이러한 다시마는 인체에 전혀 해가 없다는 것이 또한 특징이다.Alginate in kelp ingredients clears the blood by solving intestinal stool and constipation, lowering cholesterol and lowering blood pressure. Iodine in kelp lowers blood pressure by inhibiting the action of adrenaline hormones secreted by the adrenal glands. In addition, potassium (K) has a function of neutralizing sodium (salt) and suppresses an increase in blood pressure caused by sodium. Therefore, it is an excellent food for preventing and treating hypertension and diabetes, which is a chronic disease of modern people, and is effective for obesity. Naturally, it's best for stamina foods. For this reason, kelp extracts have recently been developed and widely used. This kelp is also characterized by no harm to the human body.
키틴/키토산은 수용성으로, 꽃게, 새우, 게, 버섯, 곤충의 껍질, 오징어의 뼈 등에 많이 함유되고 있는데 주로 글루코사민 결합된 다당체, 키틴도글루코사민, 키토산으로 이루어져 있다. 키토산은 신체의 조직과 유사한 구조를 이루고 있는 천연고분자 자원으로서 인체에 매우 유용하다. 키토산은 체지방의 분해 및 흡착 제거작용과 보습력 또한 높여주며 모든 사람의 미용 및 생리작용에도 탁월한 효과가 있다.Chitin / chitosan is water-soluble and contains a lot of crabs, shrimp, crabs, mushrooms, insect shells, and cuttlefish bones. It consists mainly of glucosamine-linked polysaccharides, chitindoglucosamine, and chitosan. Chitosan is a natural polymer resource that has a structure similar to that of the human body and is very useful to the human body. Chitosan also improves body fat decomposition, adsorption removal and moisturizing effects, and it is also excellent for everyone's beauty and physiology.
키틴은 매미나 거미, 바퀴벌레와 같은 곤충, 버섯같은 균류, 대부분의 어류 및 꽃게에 키틴질이 들어있는데, 피부친화력이 우수하여 화상치료용 인공피부제조이 주로 이용되고 있는데, 키틴으로 만든 인공피부는 한번 붙여 놓으면 다시 붙일 필요가 없이 화상이 치료되면서 흡수가 되어 버린다. 키틴/키토산의 사용예로서, 일본에서는 백노약(白老藥:해열), 정장(整腸)효과가 있다고 해서 게나 새우 껍질가루를 달여서 복용하였으며 화상, 피부병 치료제로 사용하는 민간요법으로 이용되고 있으며, 중국에서는 본초강목(本草綱目)을 인용해보면 종기나 부스럼치료의 특효약으로 게가루로 만든 완자를 복용하였다고 기술하고 있고, 국내의 문헌 동의보감에서는 설태라는 이름으로 오징어뼈를 위장약이나 상처의 지혈 및 치료제와 항알레르기, 부종 면역증강 등에 효험이 있다고 기술하고 있다.Chitin contains chitin in insects such as cicada spider, cockroaches, fungi such as mushrooms, and most fish and crabs. Due to its excellent skin-friendliness, chitin is used for the manufacture of artificial skin for the treatment of burns. When released, the burn will be absorbed and absorbed without the need for reattachment. As an example of the use of chitin / chitosan, in Japan, it has been used as a folk remedy for the treatment of burns and skin diseases because it has been taken with crab or shrimp shells because of its white antipyretic and antipyretic effects. In China, citing herbal herb (本草綱目), it is said that the special medicine for boil and boil treatment was taken of crab powder, and in the agreement of Korean literature, squid bone was called gestation and hemostasis and treatment of gastrointestinal drugs and wounds. It has been described as effective in anti-allergy, edema immunity, etc.
이러한 키틴의 몇가지 화학적 과정을 거치면 키토산이 되는데 키토산의 몇가지 놀라운 효능은 키토산은 자기주변의 중금속을 완벽하게 파괴시킨다. 일반 중금속 응집제에 비해서 10배의 응집력을 보인다. 폐수에 키토산을 넣으면 중금속이 조그마한 티끌들과 함께 응집되어 버린다. 그러면 응집된 부분을 골라서 폐기해 버리고 맑은 물 만 흘려보낼 수 있는 것이다. 커피에도 키토산을 넣으면 카페인성분이 응집되어 버린다. 이 키토산은 중금속뿐만 아니라 색소나 염료까지도 100%흡착해서 제거하는 힘이 있어 우리 몸에 축적된 중금속도 제거해주게 된다. 다른 응용예로 키토산에는 세균을 억제하는 항균능력과 보습효과가 우수하여 키토산 실로 기저귀제품을 만들기도 하였다. 이외에도 가장 대중적인 인기를 모은 것은 손상된 부분을 회복시켜주는 성분때문에 미용제품과 삼푸 등에 널리 이용되고 있다. 이외에도 키토산은 단지 보습효과뿐만 아니라 세포내부에 흡수되어 피부세포를 증식 활성화시키는 효과가 우수하여 화장품재료로도 많이 이용되고 있는데 특히 미정복 분야인 암을 치료할 수 있다는 희망 때문에 활발히 연구중이다. 항암치료를 전혀 하지 않은 암세포, 일반 항암제를 넣은 세포의 증식이 가장 많이 억제되었다는 연구결과도 발표되었다. 키토산에 대한 보다 상세한 내용은 대한민국공개특허 98-8299호, 미합중국 특허 5,730,876 및 일본한방의약신문(日本 韓方醫藥新聞) 1997, 3, 10일자, 보건신문 1997, 6, 16일자, 1997, 6, 23일자 보건신문에 보다 상세히 기술되어 있다.After some chemical process of chitin, it becomes chitosan. The amazing effect of chitosan is that chitosan completely destroys heavy metals around itself. It shows 10 times cohesive force compared to general heavy metal coagulant. When chitosan is added to the waste water, heavy metals coagulate with small particles. This will allow you to pick out the agglomerated parts and throw away the clear water. If you add chitosan to coffee, caffeine will aggregate. This chitosan has the power to absorb and remove not only heavy metals but also pigments and dyes, which also removes heavy metals accumulated in our bodies. In another application, chitosan has been made of chitosan yarn for diaper products due to its excellent antibacterial and moisturizing effects. In addition, the most popular is widely used in beauty products and shampoo because of the ingredients that heal damaged areas. In addition, chitosan is not only moisturizing but also absorbed into the cells and is effective in proliferating and activating skin cells. Therefore, chitosan is widely used as a cosmetic material. The results showed that the most proliferation of cancer cells that had not been treated with chemo and cells containing general anticancer drugs was most suppressed. For more information on chitosan, see Korean Patent Application Publication No. 98-8299, US Patent No. 5,730,876, and Japanese Herbal Medicine Newspaper 1997, 3 and 10, Health Newspaper 1997, 6 and 16, 1997, 6, It is described in more detail in the Health Newspaper, dated 23.
그 구조와 화학식은 다음과 같이 표현되며 생성원에 따라 알파, 베타, 감마형으로 구분되나 차이점은 거의 없다. Poly(1-4) 2-amino-2deoxy-β-D-glucan 또는 Poly(1-4) β-D-glucosamine 이라 불린다. 키틴/키토산은 독성이 없어 인체에 전혀 해가 없다는 것이 특징이다.The structure and chemical formula are expressed as follows and are divided into alpha, beta, and gamma types depending on the source, but there are few differences. It is called Poly (1-4) 2-amino-2deoxy-β-D-glucan or Poly (1-4) β-D-glucosamine. Chitin / chitosan is not toxic and is characterized by no harm to the human body.
어성초(魚腥草, Houttuynia cordata THUNBERG.)는 중약대사전을 인용하면 주성분으로는 데카노일 아세트알데히드(Decanoyl-acetaldehyde)이며, 그 밖에 매틸-엔-노닐케톤 미르세네(Myrcene), 로우릴 알데히드(Lauryl aldehyde), 케프릭 엑시트(Capric acide), 코다리에 쿠에르시트린(Quercitrin), 이소쿠에르시트린 (Isoquerctrin), 기타 칼륨염과 식이섬유, 나아아신등 영양성분이 인삼보다 많이 함유되어 있다고 기술하고 있다.Houttuynia cordata THUNBERG. Is a decanoyl-acetaldehyde whose main ingredient is cited from Chinese herbal medicine dictionary. Others include methyl-en-nonylketone Myrcene and Lauryl aldehyde. nutrients such as aldehyde), capric acide, cordier quercitrin, isoquerctrin, other potassium salts, dietary fiber, niacin, etc. .
어성초는 약명으로 어성채, 즙이근, 십약, 집약초, 중약초 등으로 불리고 있는데, 생선비린내와 같은 특이한 냄새가 난다하여 붙여진 이름으로 중국의 본초강목(本草綱目)에는 즙채로 소개되어 있다. 일찍이 중국에서는 영단초(靈丹草), 진주초(珍珠草)라 하여 소중히 여겼고, 일본에서는 독을 제거하는 다리라 하여 독교(毒矯)라 불리고 있다. 이처럼 어성초의 약효는 중국이나 일본에서는 민간약으로 널리 사용하여 왔으나, 국내에서는 극소수의 사람만이 어성초의 효능을 알고 있을 뿐 대개의 사람들은 그런 식물이 있다는 사실조차 모르고 있다.Eoseongcho is known as Eoseongchae, Succulent Root, Medicine, Medicinal Herb, Chinese Herbal Medicine, etc., and it is named after its peculiar smell like fishy fishy smell. In early China, Yeongdancho and Jinjucho were cherished. In Japan, they are called poisonous bridges as a bridge that removes poison. Thus, the effectiveness of Eoseongcho has been widely used as a folk medicine in China and Japan, but only a few people in Korea know the efficacy of Eoseongcho, and most people do not even know that there is such a plant.
어성초의 효능으로는 중약대사전과 영남채약론에 기술된 문헌을 살펴보면 특히 항균작용이 강하고, 특히 폐렴균이나 황색포도상구균, 이질균, 대장균 등에 강한 억균작용이 있다. 또한 병원세포의 발육억제 효과도 뛰어나다고 기술하고 있다.Efficacy of Eoseongcho has a strong antibacterial effect, especially in the literatures described in the Chinese herbal medicine dictionary and Yeongnam Pharmacology, especially pneumococcal, Staphylococcus aureus, dysentery, E. coli. In addition, it describes the excellent effect of inhibiting the growth of pathogenic cells.
어성초에는 항균제인 설파민보다 4만배나 항균력이 강한 데카노일 아세트 알데히드라는 휘발성 성분이 결막염, 폐렴, 간염, 위염, 피부염 등 몸 안팎의 모든 염증을 다스린다고 한다. 특히 결명자차와 함께 먹으면 협심증에는 특효약이며, 또한 간의 해독작용도 도와 숙취에도 매우 효과적이며 매일 꾸준히 어성초를 섭취한다면 심장질환에 수반되는 모든 증상의 개선에 도움을 준다. 어성초는 생즙을 먹을 때 가장 효과적이고, 갑상선, 전립선은 물론 면역기능의 강화로 항암효과도 있다고 한다. 이 뿐만 아니라 미용실에서 어성초를 주문할 정도로 피부미용에도 매우 효과적이다. 현 산업사회의 부산물인 공해의 독소로부터 몸에서 그 독을 몰아내고 체내 정화작용하고, 장을 깨끗하게 하고 위를 튼튼하게 하여 만성변비를 해소하는데 효과가 우수하다. 그리고 어성초의 성분중 쿠에르시트린과 이소쿠에르시트린 혈액순환을 촉진시키고 혈압을 조정하며 혈액청혈 및 혈관강화에 효능이 탁월하다.In Echoseongcho, decanoyl acetaldehyde, which is 40,000 times more effective than the antiseptic sulfamine, is said to treat all inflammations inside and outside the body such as conjunctivitis, pneumonia, hepatitis, gastritis and dermatitis. In particular, when eating with a clear tea, angina is an effective medicine for angina, and also the liver detoxification effect is very effective for hangover, and if you continue to eat eoseongcho every day helps to improve the symptoms associated with heart disease. Eoseongcho is the most effective when eating the juice, the thyroid gland, the prostate gland, as well as anti-cancer effect by strengthening immune function. Not only that, it is also very effective for skin care as you order Eochocho in beauty salon. It is very effective in removing the poison from the body by toxins of the current industrial society, purifying the body, purifying the body, and clearing the intestines and strengthening the stomach to relieve chronic constipation. Among the ingredients of Eochocho, Cuercitrine and Isoquercitrin promote blood circulation, regulate blood pressure, and are excellent in blood serum and blood vessel strengthening.
어성초의 약리작용으로는 항암, 이뇨, 강심, 해독, 정장, 거담, 진통, 지혈, 조직재생, 피부미용, 미발 등이 있다. 어성초 역시 독성이 없어 인체에 전혀 해(害) 없다.Pharmacological action of Eoseongcho include anti-cancer, diuresis, cardiac, detoxification, suit, expectoration, analgesic, hemostasis, tissue regeneration, skin care, and hair. Eoseongcho is also nontoxic and does not harm the human body at all.
문형은 사포닌인 에쿠이세토닌, 배당체인 에쿠이세트린, 이소퀘치트린, 갈루테올린, 구산, 유기산 기름, 베타-시토스테롤, 팔루스트린, 및 아미노산으로 이루어져 있는데, 문헌 동의보감을 보면 문형은 열내림 특히 혈액의 열을 강하시키는 작용이 우수하고, 이뇨작용, 류머티스 관절염, 신경통증에 탁월한 효과가 있다고 기술하고 있다. 문형 역시 독성이 없어 인체에 전혀 해가없다는 것이 특징이다.The sentence pattern consists of saponins, equicetonin, glycosides, equasetrin, isoquattrin, galoteolin, guic acid, organic acid oil, beta-sitosterol, palustrin, and amino acids. It is said to have a good effect of lowering blood heat, and has an excellent effect on diuretic, rheumatoid arthritis and neuralgia. The sentence type is also characterized by no toxicity to the human body.
함초(Salicomia herbacea)에는 마그네슘, 칼슘, 칼륨, 철, 인, 요오드, 나트륨, 염분 및 기타 천연식물성섬유질 효소균 각종 미네랄이 포함되어 있다. 함초에는 어떤 식품보다 많은 미네랄이 들어 있는데 칼슘은 우유보다 7배가 많고 철은 김이나 다시마의 40배나 되며 칼륨은 굴보다 3배가 많다. 이밖에 바닷물 속에 들어 있는 90여 가지의 미네랄이 골고루 들어 있다. 그래서 맛이 몹시 짜나 소금기 가운데 해로운 물질들은 걸러내고 이로운 물질만을 받아들여 약초로서 탁월한 효능을 나타낸다. 중국의 옛 본초서인 신농본초경에는 맛이 몹시 짜다 하여 함초 또는 염초, 또 몹시 희귀하고 신령스러운 풀로 여겨 신초로 표현하고 있고, 국내에서는 톳나물로 널리 알려져 있으며, 중약대사전에서는 이형사초(異形沙草. Cyperus difformis)라고 쓰여 있다.Salvia (Salicomia herbacea) contains magnesium, calcium, potassium, iron, phosphorus, iodine, sodium, salts and other natural plant fiber enzymes and various minerals. The seaweed contains more minerals than any other food, calcium is seven times more than milk, iron is 40 times more than seaweed or kelp, and potassium is three times more than oysters. In addition, there are more than 90 minerals in the sea. Therefore, the taste is very salty, but the harmful substances in the salt filter out and accept only the beneficial substances, showing excellent efficacy as herbs. The ancient Chinese herbaceous book, Xinonghuo, has a very salty taste, and it is expressed as a seaweed or salt, or a very rare and spiritual grass. It is widely known as a botanical herb in Korea. Cyperus difformis).
그러나 함초는 국내 어떤 의학책에도 언급된 바 없으나 오래 전부터 관심을 갖고 연구해 온 일본의 오하라산장 난치병연구소의 이토 소장은 함초가 갖가지 암, 축농증, 관절염, 고혈압, 저혈압, 요통, 비만증, 치질, 당뇨병, 갑상선염, 천식, 기관지염 등에 주로 뛰어난 효과가 있다고 발표한 바 있다.However, seaweed has not been mentioned in any medical book in Korea, but Ito's director at Ohara Institute for Intractable Disease Research in Japan has been interested in research for a long time. It has been reported to have a major effect on thyroiditis, asthma and bronchitis.
일반적으로 중국 한방문헌 본초서를 인용하면 함초는 장내 연동운동으로 장벽에 겹쳐진 주름사이사이를 맑게 세척하여 장벽에 축적된 숙변과 그로 인한 독소를 제거하고, 장벽에 서식하는 부패균에 의한 혈액의 혼탁을 맑게하거나(정혈작용) 예방하는 청혈작용을 한다고 기술되어 있다. 또 장내의 융털의 기능을 부할시켜 음식물의 영양분을 제대로 흡수할 수 있도록 해준다. 그리고, 혈액에 적혈구가 세포로 바뀌면서 파괴된 세포를 재생시키는 작용을 한다고 밝히고 있다. 함초를 먹으면 대개 숙변이 빨리 나오는 사람은 1∼2개월만에 나타나는데 함초가 숙변을 분해하고 장관을 자극하고 수축시키기 때문에 대개 배가 살살 아프다가 숙변이 나오게 되는 것이다. 함초를 먹고 나면 장이 있는 부위가 뻐근하게 아프고 쿡쿡 쑤시거나 꾸륵꾸륵 소리가 나는 등의 증상이 나타나는 사람도 있다.In general, quoted from the Chinese herbal literature, the seaweed is cleared between the wrinkles superimposed on the barrier by the intestinal peristalsis movement to remove the stool accumulating on the barrier and its toxins, and to clear the turbidity of the blood due to the decaying bacteria living on the barrier It is said to have a blue blood function or to prevent (hypostatic action). In addition, by injecting the function of the intestinal filaments, it is able to properly absorb food nutrients. In addition, the red blood cells in the blood turns into cells to regenerate the action of the destroyed cells. Eating persimmons usually occurs quickly in one or two months when people come out quickly, because hamcho breaks down the stool, stimulates the intestines and contracts, so the belly is usually aching pains come out. Some people may have symptoms such as tingling, squeaking or squealing when the intestinal area is ill after eating the seaweed.
또 변에서 냄새가 심하게 나고 몸에서도 냄새가 나며 배에 가스가 차고 졸음이 오거나 머리가 띵해지는 등의 증상이 일시적으로 나타나기도 한다. 습진이나 가려움증 같은 피부병이 생기는 경우도 있는데 이는 간장이나 신장의 기능이 허약해 몸안에서 분해된 독소를 간장과 신장이 다 처리하지 못함으로써 독소가 피부를 통해 밖으로 배출되기 때문에 일어나는 증상이다.In addition, the stool smells badly, the body smells, and the stomach becomes gassy, drowsiness, or steaming. In some cases, skin diseases such as eczema and itching are caused by the weak function of the liver or kidneys, which is caused by the toxins being released through the skin because the liver and kidneys cannot process the toxins that are broken down in the body.
이같은 반응은 모두 몸안에 쌓여 있던 노폐물과 독이 분해돼 몸밖으로 빠져 나갈 곳을 찾아 움직이면서 일어나는 증상으로 함초는 장을 깨끗하게 하는데는 가장 이상적인 식물이라 할 수 있다. 그밖에도 함초는 고혈압과 저혈압을 동시에 치료하며, 갖가지 관절수종, 근육유연작용, 염증 및 관절염으로 인해 붓는 것을 치료하며, 여성에게는 숙변의 제거로 인해 2차적으로 피부를 아름답게(미백효과) 즉, 기미, 주근깨, 여드름 등의 치료에 효과적이다. 또 위장기능도 좋아지며, 기관지천식과 기관지염, 당뇨병, 갖가지 암등에 효과가 있는데 함초에는 항암작용이 있어 암세포의 성장을 억제하며 특히 자궁근종에 효과가 높다. 무엇보다도 함초는 독성이 없어 인체에 전혀 해가 없다는 것이다.All of these reactions occur when the wastes and poisons accumulated in the body are broken down and moved out of the body looking for a place to move out. The seaweed is the ideal plant to clean the intestines. In addition, sea bream treats hypertension and hypotension at the same time, and cures swelling due to various joint edema, myeloflexion, inflammation, and arthritis. In other words, it is effective in treating blemishes, freckles, and acne. In addition, the gastrointestinal function is also good, bronchial asthma, bronchitis, diabetes, various cancers, etc., the effect of the anti-cancer effect of the cancer cells to inhibit the growth of cancer cells, especially high myoma. Above all, seaweed is not toxic and harmless to the human body.
본 발명에 따른 건강보조식품 제조방법에 대하여 설명하면 다음과 같다.Referring to the health supplement manufacturing method according to the invention as follows.
관절염과 신경계 치료제는 함초, 어성초, 키틴/키토산, 배아, 문형를 건조시킨 뒤 이를 각각 이를 미립자로 분말화시킨 뒤 함초 약 30∼50중량%, 어성초 약 15∼30중량%, 키틴/키토산 약 30∼50중량%, 배아 5∼15중량%, 문형3∼10중량% 비율로 혼합한다.Arthritis and nervous system treatments are dried seaweed, fish vinegar, chitin / chitosan, embryo, sentence pattern, and then powdered into fine particles, respectively, about 30 to 50% by weight, about 15 to 30% by weight eochocho, about 30 ~ chitin / chitosan 50 weight%, 5-15 weight% of embryos, and 3 to 10 weight% of molds are mixed.
위와 같이 혼합된 혼합물을 물을 넣어 반죽하여 약 15∼20g의 환(丸)으로 제조하거나 분말을 10∼20g의 양을 캡슐(Capsule)속에 넣어 캡슐화한다. 물론 환(丸) 혹은 캡슐화하지 않더라도 분말형태로 복용해도 무방하다.The mixture as described above is kneaded with water to prepare about 15 to 20 g of 丸 (하거나) or powder to encapsulate the amount of 10 to 20 g into a capsule (Capsule). Of course, you can take it in powder form, even if it is not round or encapsulated.
상기한 함초는 약 30내지 50중량% 이상 혼합하면 1차적으로 장내의 숙변을 제거하여 장청소 효과가 우수하고 관절의 근육을 부드럽게 풀어주고 갖가지 염증 및 관절염으로 인해 붓는 것을 완화시켜 준다. 이러한 약리작용중 50중량% 이상 되면 효과중 관절수종, 근육유연작용, 염증 및 관절염치료보다 장청소작용이 더 활발해짐으로 약 35중량% 정도가 바람직하다. 그리고, 혈압을 안정시켜 주며, 요통, 당뇨 갑상선염, 기관지염에도 우수한 효능이 있다.When the above-mentioned seaweed mixes about 30 to 50% by weight or more, the bowel cleansing effect is excellent by first removing the bowel stool in the intestine, and softens the muscles of the joint and relieves swelling due to various inflammations and arthritis. If more than 50% by weight of the pharmacological effect of the effect of the bowel cleansing activity more than the treatment of arthropathy, muscle flexibility, inflammation and arthritis is about 35% by weight is preferred. In addition, it stabilizes blood pressure and has excellent efficacy in low back pain, diabetes thyroiditis and bronchitis.
상기한 어성초는 약 15∼30중량%로 혼합하면 특히 진통효과가 우수하여 관절통증을 완화시키고 관절상에 유해독소를 해독하고 조직세포를 활성화시켜 준다. 가장 바람직한 혼합비율은 약 20중량%이다.,The fish vinegar is mixed with about 15 to 30% by weight is particularly excellent analgesic effect to relieve joint pain, detoxify harmful toxins on the joints and activate tissue cells. The most preferable mixing ratio is about 20% by weight.
상기한 키틴/키토산은 전술한 바와 인체내에 축적된 중금속을 응집하여 외부로 배출시키는 작용을 하며 손상된 세포에 흡수되면서 세포재생을 활성화시켜 관절이상을 빠르게 회복시켜주게 된다. 키틴/키토산의 가장 바람직한 혼합비율은 약 35중량%이다. 키토산에 의해 간세포의 재생에 많은 도움을 주어 간경화나 간염등에도 좋은 효과를 낸다.The chitin / chitosan acts to agglomerate heavy metal accumulated in the human body as described above and discharge it to the outside, and is activated by cell regeneration as it is absorbed by damaged cells, thereby rapidly recovering joint abnormalities. The most preferred mixing ratio of chitin / chitosan is about 35% by weight. Chitosan helps the regeneration of hepatocytes and has a good effect on liver cirrhosis and hepatitis.
상기한 배아의 바람직한 혼합비는 배아 3∼10중량%로서, 비타민B2에 의해 성장을 촉진시키고, 피를 맑게(정혈작용) 해주며 인체 전반에 활력을 넣어준다. 배아의 가장 바람직한 비율은 약 4중량%이다.The preferred mixing ratio of the embryo is 3 to 10% by weight of the embryo, promotes growth by vitamin B2, clears the blood (hypostatic action) and puts vitality throughout the human body. The most preferred proportion of embryos is about 4% by weight.
상기한 문형은 3∼10중량%를 혼합하면 앞서 설명한 바와 같이 열내림 특히 혈액의 열을 강하시키는 작용을 하고, 이뇨작용, 류머티스 관절염, 신경통증에 탁월한 효과가 있다. 가장 바람직한 비율은 7중량%이다. 그리고 문형에 의해 신장의 기능이 호전되어 신장질환 환자에게 매우 유익하다.When the above sentence is mixed 3 to 10% by weight, as described above, the function of lowering the heat of blood, in particular, lowering the heat of the blood, has an excellent effect on diuretic action, rheumatoid arthritis, neuralgia. The most preferable ratio is 7 weight%. In addition, the kidney function is improved by the sentence, which is very beneficial to patients with kidney disease.
상기와 같이 혼합된 건강보조식품의 주된 효능을 보면, 환자는 초기에 장속의 숙변과 혈액속에 독성이 일차적으로 서서히 배출되기 시작하고, 관절부위의 부기가 빠지기 시작하면서 몸이 가벼워지기 시작한다. 그리고 혈압이 안정적으로 유지되고, 세포의 증식의 활성화로 인해 관절통증이 서서히 감소되기 시작하면서 통증이 사라지게 된다. 아울러, 간접적인 효능으로는 뇌경색과 간기능이 향상되고, 고혈압이 안정되며, 혈액순환이 원활해진다. 물론 숙변제거로 인해 변비등과 같은 증상이 개선되고, 내장기능이 활발해지며, 영양분의 흡수율이 매우 높아진다.In view of the main efficacy of the mixed dietary supplement as described above, the patient initially begins to gradually discharge the toxic stool in the bowel and blood in the intestine in the beginning, the swelling of the joint area begins to lighten the body. The blood pressure remains stable and the pain disappears as joint pain gradually begins to decrease due to activation of cell proliferation. In addition, indirect efficacy is improved cerebral infarction and liver function, high blood pressure is stabilized, blood circulation is smooth. Of course, elimination of stool, such as constipation, such as symptoms, improves, visceral function is active, nutrient absorption is very high.
이상에서 설명한 바와 같은 본 발명의 건강보조식품제조방법은 복용후 약 1∼2개월정도 경과하면 명현반상이 나타나기 시작하는데, 개개인의 체질과 체력에 따라 그 현상은 다소 차이가 있다. 명현현상은 호전반응이라고도 한다. 따라서, 만성질환을 가지고 있는 사람이 건강식품이나 기능식품을 섭취하게 되면, 비교적 빠른 시기에 부작용이 아닌가? 라고 생각되는 호전반응이 나타나기도 한다. 이러한 호전반응은 증상이 개선되고 있다는 바람직한 반응들이다. 호전반응은 체질이나 병질에 따라 증상도 여러 가지로 나타나는데 그 예들은 아래와 같다.As described above, the manufacturing method of the health supplement food of the present invention begins to appear a light phenomenon about 1 to 2 months after taking, the phenomenon is somewhat different depending on the constitution and physical strength of the individual. Ming phenomena are also referred to as reactions. Therefore, if a person with a chronic disease ingests a health food or a functional food, is it a side effect in a relatively early time? I think there is an improvement in response. These favorable reactions are desirable reactions that symptoms are improving. Amelioration reactions appear in various ways depending on the constitution or disease. Examples are as follows.
(1) 이완반응 - 졸립다. 나른하다 등의 증상으로 만성질환에 많고 나쁜 장기가 기능을 회복함에 따라 일어나는 일시적인 밸런스 무너짐이 원인이다.(1) Relaxation-Sleepy. Symptoms such as drowsiness is caused by a temporary balance breakdown that occurs as many bad organs return to function.
(2) 과민반응 - 변비, 설사, 동통, 종기, 발한의 증상으로 만성질환으로 이행되는 중에 장기에 '회복시키는 힘'이 작용했을 때 일어나는 반발성 급성 증상이다..(2) Hypersensitivity reactions-Symptoms of constipation, diarrhea, pain, boils, and sweating. This is a repulsive acute symptom that occurs when the body's 'recovering power' is applied during the transition to chronic disease.
(3) 배설반응 - 부스럼, 피부반점, 발진, 뾰루지, 눈이 충혈되거나 눈꼽 등의 증상으로 체내의 노폐물, 독소를 분해하고 땀, 소변, 피부 등으로 배출하기 위해 일어나는 증상으로 가장 많은 호전반응이다.(3) Excretion-Symptoms such as swelling, skin spots, rashes, rashes, redness of the eyes or nausea, are symptoms that occur to break down waste products and toxins in the body and release them to sweat, urine, and skin. .
(4) 혈액순환의 회복반응 - 발열, 통증, 구토, 복통, 손발절임 등의 증상으로 이는 혈액의 흐름이 좋아진 증거이다.(4) Recovery of blood circulation-Symptoms such as fever, pain, vomiting, abdominal pain and hand and foot joints, which is evidence of improved blood flow.
이들 호전반응은 2∼3개월 정도가 지나면 자연히 사라져 정상적으로 돌아온다.After two to three months, these reactions naturally disappear and return normally.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019990038463A KR20010026947A (en) | 1999-09-09 | 1999-09-09 | Sub-food manufecturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019990038463A KR20010026947A (en) | 1999-09-09 | 1999-09-09 | Sub-food manufecturing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010026947A true KR20010026947A (en) | 2001-04-06 |
Family
ID=19610829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019990038463A KR20010026947A (en) | 1999-09-09 | 1999-09-09 | Sub-food manufecturing method |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20010026947A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010044175A (en) * | 1999-12-24 | 2001-06-05 | 장태순 | Method for inhibiting synthesis and secretion of cell activating substances using chitosan and Food composition comprising chitosan for the inhibition |
| KR20020044670A (en) * | 2000-12-06 | 2002-06-19 | 이성조 | Solid, liquid Health foods containing the extracts derived from Salicornia herbacea L. as an active ingredient and manufacturing therof |
| KR100422213B1 (en) * | 2001-12-15 | 2004-03-11 | 백이호 | Kimchi containing middot and producing method of the same |
| EP1491202A1 (en) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
| KR100755515B1 (en) * | 2001-05-04 | 2007-09-05 | 이진태 | Functional drinks using Salicornia herbacea and a method of manufacturing process |
| KR100793826B1 (en) * | 2006-07-26 | 2008-01-11 | 신안군 | Preparing method of coated rice using salicornia herbacea extracts and arginic acid |
-
1999
- 1999-09-09 KR KR1019990038463A patent/KR20010026947A/en not_active Application Discontinuation
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010044175A (en) * | 1999-12-24 | 2001-06-05 | 장태순 | Method for inhibiting synthesis and secretion of cell activating substances using chitosan and Food composition comprising chitosan for the inhibition |
| KR20020044670A (en) * | 2000-12-06 | 2002-06-19 | 이성조 | Solid, liquid Health foods containing the extracts derived from Salicornia herbacea L. as an active ingredient and manufacturing therof |
| KR100755515B1 (en) * | 2001-05-04 | 2007-09-05 | 이진태 | Functional drinks using Salicornia herbacea and a method of manufacturing process |
| KR100422213B1 (en) * | 2001-12-15 | 2004-03-11 | 백이호 | Kimchi containing middot and producing method of the same |
| EP1491202A1 (en) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
| WO2004112814A1 (en) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
| CN100430044C (en) * | 2003-06-23 | 2008-11-05 | 波利化学公司 | Nail restructuring compositions for topical application |
| KR101140272B1 (en) * | 2003-06-23 | 2012-04-26 | 폴리켐 에스.아. | Nail restructuring compositions for topical application |
| KR100793826B1 (en) * | 2006-07-26 | 2008-01-11 | 신안군 | Preparing method of coated rice using salicornia herbacea extracts and arginic acid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105412623A (en) | Medicament for treating fatty liver, prostatitis, nephralgia, nephritis, hypertension and diabetes | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| KR20170142756A (en) | composition and method thereof | |
| KR20010026947A (en) | Sub-food manufecturing method | |
| CN103908592A (en) | Traditional Chinese medicine for detoxification and preparation method of traditional Chinese medicine | |
| KR20180005056A (en) | Thrombolytic agent composition using the natural | |
| CN102824626A (en) | Medicine combined soaking preparation for treating anaphylactic rhinitis and preparation method thereof | |
| CN1275642C (en) | Umbilicus sticking powder for treating child aversion to food | |
| CN102824414A (en) | Medicinal tea used for treating constipation | |
| JPH0761953B2 (en) | Manufacturing method of immunity strengthening and constitution improving agent | |
| CN112076305A (en) | A Chinese medicinal oral and topical stock solution mixture for treating metabolic syndrome and resisting bacteria and inflammation | |
| CN105168522A (en) | Medicament for treating abdominal distension and preparation method thereof | |
| CN109258976A (en) | Chinese medicine additive in one breeding hen feed | |
| CN103211988B (en) | Pharmaceutical composition for treating porcine infectious gastrointestinal inflammations | |
| CN108126114B (en) | Traditional Chinese medicine sustained-release particle medicated diet for detoxifying and expelling toxins and preparation method thereof | |
| CN106074785A (en) | A kind of Chinese medicinal formulae treating cattle diarrhea due to damp-heat and preparation method thereof | |
| CN106262801A (en) | A kind of nutrient formulation nano-particle preventing and treating thrombophlebitis and preparation processing method | |
| CN104547430A (en) | Traditional Chinese medicine granules for treating infantile convulsion and preparation method of traditional Chinese medicine granules | |
| CN110694014A (en) | A composition for preventing and treating thrombosis | |
| CN103316183A (en) | Traditional Chinese medicine preparation for treating kidney deficiency and preparation method therefor | |
| CN109289001A (en) | A kind of Chinese medicine composition and preparation method thereof for treating kidney stone | |
| CN117838823A (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN114832038A (en) | Traditional Chinese medicine composition for treating arthralgia and myalgia and preparation method thereof | |
| CN111728187A (en) | Whitebait sauce and preparation method thereof | |
| KR20190042147A (en) | Composition for treating edema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Withdrawal due to no request for examination |